SRF boosts fluoropolymer investment, reports strong Q2 growth

SRF Limited announced a revised capital expenditure of INR 745 crore for its specialty fluoropolymers project, an increase from the previously sanctioned INR 595 crore. This adjustment follows strategic agreements with The Chemours Company for manufacturing, supply, and distribution of fluoropolymers and fluoroelastomers, necessitating a change in project scope. The project is expected to be completed by December 2026, with financing through a mix of debt and internal accruals.

The company reported strong consolidated financial results for Q2 FY26, with revenue increasing 6% to INR 3,640 crore and profit after tax (PAT) surging 93% to INR 388 crore compared to the corresponding period last year. For the half year, revenue grew 8% to INR 7,459 crore, and PAT increased 81% to INR 820 crore. The chemicals business led this growth with a 23% increase in segment revenue and a 96% rise in operating profit.

Concurrently, SRF announced the resignation of Rahul Jain, president and chief financial officer, effective December 12, 2025, as he pursues external opportunities. The company is actively seeking a successor to ensure a smooth transition. SRF continues to demonstrate innovation, having filed 501 patents and being granted 153 globally as of September 30, 2025.